Before a prospective hyperthermia patient is seen in our clinic, we usually ask that the candidate obtain the following tests through their own family doctor or oncologist:

  1. A Stress MUGA (test of heart function during exercise)
  2. Complete pulmonary function studies with arterial blood gases (test of respiratory function)
  3. CT or MRI scan of the brain - with and without either contrast or gadolinium (to rule out
  4. cancer metastases to the brain).

We review these test results before the patient is evaluated here. The results of these three studies must meet protocol requirements. If they do not, we cannot enroll a patient in our hyperthermia treatment protocol.  Before the candidate schedules an appointment, please FAX the results to us. This will allow us to determine in advance whether he or she is eligible for protocol treatment.  The above listed studies are not the only procedures that will need to be done before the first cycle of hyperthermia, but the above three tests are necessary before we can move forward.

Other staging studies that will be necessary before enrollment in the program are:

  1. CT scans of the chest, abdomen and pelvis (with and without contrast)
  2. Pulmonary function studies with a diffusion capacity
  3. Bone scan
  4. Bone marrow aspirate and biopsy
  5. Electrocardiogram (ECG)
  6. Laboratory blood and urine tests.

These tests (1-3, and a-f) must be perfomed within the 30 days prior to the first treatment. Also, we must have the actual pathology slides and a copy of the written surgical pathology report from which the diagnosis was made. The actual pathology slides and the actual films from most recent CT and bone scan studies (with copies of the pathology and radiological reports) should be brought to the first visit for our evaluation, if they have not already been received in our office. The pathology slides and the radiological CT scan films will be returned to the institution that provided them. If we do not have these films, slides and reports at the time of the initial visit, we will need to repeat the tests here before a treatment may be given.

Each patient also needs a central venous access line (CV line) placed prior to the start of treatment. We administer chemotherapy drugs through this line. If desired, the CV line can be placed at our institution.

Created in the Division of Oncology at The University of Texas Houston Medical School
MSB 5.281, 6431 Fannin, Houston, TX 77030; Tel: 713-500-6821
Last updated on March 22, 2009
email questions to the webmaster at oncologyweb
The content of these pages is intended for information and educational purposes. It should not be construed as medical diagnosis or treatment.